Ackman's Pershing Square Capital Raises Stake in Valeant Pharmaceuticals (VRX) to 9.9%
Tweet
Share
E-mail
In an amended 13D filing on Valeant Pharmaceuticals (NYSE: VRX), Bill Ackman's hedge fund Pershing Square Capital disclosed a 9.9%, or 34,118,551 share, stake in the company. This is up 75.20% from the 19,473,933 shares held at the end of the latest quarter ending September 30, 2015.
For more notable holders of Valeant Pharmaceuticals stock click here. For more information on Pershing Square Capital click here.
Name | Trade Date | Buy/Sell/Exercise | No. of Shares / Quantity | Unit Cost | Strike Price | Trade Amount | Security | Expiration Date | ||||||||||||||||
Pershing Square Holdings, Ltd. | October 1, 2015 | Buy | 172,748 | $ | 178.38 | N/A | $ | 30,814,788 | * | Common Stock | N/A | |||||||||||||
Pershing Square Holdings, Ltd. | October 21, 2015 | Buy | 870,501 | $ | 108.13 | N/A | $ | 94,127,099 | Common Stock | N/A | ||||||||||||||
Pershing Square Holdings, Ltd. | October 21, 2015 | Buy | 1,584 | $ | 4.35 | $ | 120.00 | $ | 689,764 | Listed Call Option | October 23, 2015 | |||||||||||||
Pershing Square Holdings, Ltd. | November 20, 2015 | Buy to Open | 3,687,444 | $ | 23.65 | $ | 95.00 | $ | 87,208,051 | OTC Call Option | January 20, 2017 | |||||||||||||
Pershing Square Holdings, Ltd. | November 20, 2015 | Sell to Open | 3,687,444 | $ | 3.90 | $ | 165.00 | $ | 14,381,032 | OTC Call Option | January 20, 2017 | |||||||||||||
Pershing Square Holdings, Ltd. | November 20, 2015 | Sell to Open | 3,687,444 | $ | 13.00 | $ | 60.00 | $ | 47,936,772 | OTC Put Option | January 20, 2017 | |||||||||||||
Pershing Square II, L.P. | October 21, 2015 | Buy | 15,656 | $ | 108.13 | N/A | $ | 1,692,880 | Common Stock | N/A | ||||||||||||||
Pershing Square II, L.P. | October 21, 2015 | Buy | 27 | $ | 4.35 | $ | 120.00 | $ | 11,757 | Listed Call Option | October 23, 2015 | |||||||||||||
Pershing Square II, L.P. | November 20, 2015 | Buy to Open | 63,122 | $ | 23.65 | $ | 95.00 | $ | 1,492,835 | OTC Call Option | January 20, 2017 | |||||||||||||
Pershing Square II, L.P. | November 20, 2015 | Sell to Open | 63,122 | $ | 3.90 | $ | 165.00 | $ | 246,176 | OTC Call Option | January 20, 2017 | |||||||||||||
Pershing Square II, L.P. | November 20, 2015 | Sell to Open | 63,122 | $ | 13.00 | $ | 60.00 | $ | 820,586 | OTC Put Option | January 20, 2017 | |||||||||||||
Pershing Square II, L.P. | November 23, 2015 | Buy | 39,401 | $ | 93.83 | N/A | $ | 3,696,815 | Common Stock | N/A | ||||||||||||||
Pershing Square II, L.P. | November 23, 2015 | Sell | 39,401 | $ | 88.25 | N/A | $ | 3,477,074 | Common Stock | N/A | ||||||||||||||
Pershing Square II, L.P. | November 23, 2015 | Buy to Open | 82,230 | $ | 5.57 | $ | 100.00 | $ | 458,350 | OTC Call Option | February 8, 2016 | |||||||||||||
Pershing Square II, L.P. | November 23, 2015 | Sell to Open | 82,230 | $ | 1.01 | $ | 130.00 | $ | 83,052 | OTC Call Option | February 8, 2016 | |||||||||||||
Pershing Square II, L.P. | November 23, 2015 | Sell to Open | 82,230 | $ | 3.38 | $ | 70.00 | $ | 277,937 | OTC Put Option | February 8, 2016 | |||||||||||||
Pershing Square International, Ltd. | October 1, 2015 | Sell | 137,353 | $ | 178.38 | N/A | $ | 24,501,028 | * | Common Stock | N/A | |||||||||||||
Pershing Square International, Ltd. | October 21, 2015 | Buy | 662,043 | $ | 108.13 | N/A | $ | 71,586,577 | Common Stock | N/A | ||||||||||||||
Pershing Square International, Ltd. | October 21, 2015 | Buy | 1,208 | $ | 4.35 | $ | 120.00 | $ | 526,032 | Listed Call Option | October 23, 2015 | |||||||||||||
Pershing Square International, Ltd. | November 20, 2015 | Buy to Open | 2,837,875 | $ | 23.65 | $ | 95.00 | $ | 67,115,744 | OTC Call Option | January 20, 2017 | |||||||||||||
Pershing Square International, Ltd. | November 20, 2015 | Sell to Open | 2,837,875 | $ | 3.90 | $ | 165.00 | $ | 11,067,713 | OTC Call Option | January 20, 2017 | |||||||||||||
Pershing Square International, Ltd. | November 20, 2015 | Sell to Open | 2,837,875 | $ | 13.00 | $ | 60.00 | $ | 36,892,375 | OTC Put Option | January 20, 2017 | |||||||||||||
Pershing Square, L.P. | October 1, 2015 | Sell | 35,395 | $ | 178.38 | N/A | $ | 6,313,760 | * | Common Stock | N/A | |||||||||||||
Pershing Square, L.P. | October 21, 2015 | Buy | 596,418 | $ | 108.13 | N/A | $ | 64,490,559 | Common Stock | N/A | ||||||||||||||
Pershing Square, L.P. | October 21, 2015 | Buy | 1,081 | $ | 4.35 | $ | 120.00 | $ | 470,729 | Listed Call Option | October 23, 2015 | |||||||||||||
Pershing Square, L.P. | November 20, 2015 | Buy to Open | 2,531,559 | $ | 23.65 | $ | 95.00 | $ | 59,871,370 | OTC Call Option | January 20, 2017 | |||||||||||||
Pershing Square, L.P. | November 20, 2015 | Sell to Open | 2,531,559 | $ | 3.90 | $ | 165.00 | $ | 9,873,080 | OTC Call Option | January 20, 2017 | |||||||||||||
Pershing Square, L.P. | November 20, 2015 | Sell to Open | 2,531,559 | $ | 13.00 | $ | 60.00 | $ | 32,910,267 | OTC Put Option | January 20, 2017 | |||||||||||||
Pershing Square, L.P. | November 23, 2015 | Buy | 1,580,599 | $ | 93.83 | N/A | $ | 148,302,131 | Common Stock | N/A | ||||||||||||||
Pershing Square, L.P. | November 23, 2015 | Sell | 1,580,599 | $ | 88.25 | N/A | $ | 139,485,295 | Common Stock | N/A | ||||||||||||||
Pershing Square, L.P. | November 23, 2015 | Buy to Open | 3,297,770 | $ | 5.57 | $ | 100.00 | $ | 18,381,770 | OTC Call Option | February 8, 2016 | |||||||||||||
Pershing Square, L.P. | November 23, 2015 | Sell to Open | 3,297,770 | $ | 1.01 | $ | 130.00 | $ | 3,330,748 | OTC Call Option | February 8, 2016 | |||||||||||||
Pershing Square, L.P. | November 23, 2015 | Sell to Open | 3,297,770 | $ | 3.38 | $ | 70.00 | $ | 11,146,463 | OTC Put Option | February 8, 2016 | |||||||||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SpaceX Shares Indicated To Open At $155
- Howard Hughes Holdings completes $2.1 billion Vantage acquisition
- First Advantage to join S&P SmallCap 600, replacing Kennedy-Wilson
Create E-mail Alert Related Categories
13Ds, Hedge Funds, Short Sales, Trader TalkRelated Entities
William Ackman, Pershing Square Capital, 13DSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
